Jasper Therapeutics, Inc.
Clinical trials sponsored by Jasper Therapeutics, Inc., explained in plain language.
-
Asthma drug trial halted early, but shows promise
Disease control TerminatedThis study tested a single dose of briquilimab in 17 adults with mild-to-moderate allergic asthma to see if it could reduce allergic reactions and improve breathing. The trial was terminated early, so results are limited. The goal was to find a new way to control asthma symptoms …
Phase: PHASE1 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Hive drug trial halted: new hope for Cold-Triggered itch?
Symptom relief TerminatedThis trial tested a single dose of a drug called briquilimab in adults with chronic hives caused by cold or pressure that antihistamines couldn't control. The study aimed to check safety and see if it reduces symptoms. However, the trial was terminated early, so results are limit…
Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC